<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">AES</journal-id>
<journal-id journal-id-type="hwp">spaes</journal-id>
<journal-id journal-id-type="nlm-ta">Aesthet Surg J</journal-id>
<journal-title>Aesthetic Surgery Journal</journal-title>
<issn pub-type="ppub">1090-820X</issn>
<issn pub-type="epub">1527-330X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1090820X12455658</article-id>
<article-id pub-id-type="publisher-id">10.1177_1090820X12455658</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
<subj-group subj-group-type="heading">
<subject>Special Topic</subject>
</subj-group>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>80</subject>
<subject>350</subject>
<subject>880</subject>
<subject>960</subject>
<subject>970</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Fat Grafting’s Past, Present, and Future</article-title>
<subtitle>Why Adipose Tissue Is Emerging as a Critical Link to the Advancement of Regenerative Medicine</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Hsu</surname><given-names>Vivian M.</given-names></name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Stransky</surname><given-names>Carrie A.</given-names></name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Bucky</surname><given-names>Louis P.</given-names></name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Percec</surname><given-names>Ivona</given-names></name>
<degrees>MD, PhD</degrees>
</contrib>
<aff id="aff1-1090820X12455658">Division of Plastic Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-1090820X12455658">Dr Ivona Percec, Assistant Professor of Surgery, Division of Plastic Surgery, Hospital of the University of Pennsylvania, 3400 Spruce St, 10 Penn Tower, Philadelphia, PA 19104, USA. E-mail: <email>Ivona.Percec@uphs.upenn.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<volume>32</volume>
<issue>7</issue>
<fpage>892</fpage>
<lpage>899</lpage>
<history>
<date date-type="accepted">
<day>9</day>
<month>4</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© 2012 The American Society for Aesthetic Plastic Surgery, Inc.</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">American Society for Aesthetic Plastic Surgery, Inc.</copyright-holder>
</permissions>
<abstract>
<p>Fat grafting is a common reconstructive and aesthetic procedure with extensive clinical applications. Recently, significant strides have been made in investigating the biology behind the success of this procedure. Surgeons and scientists alike have advanced this field by innovating fat graft harvesting and injection techniques, expanding the use of adipose tissue and its stem cell components, and broadening our understanding of the viability of fat grafting at the molecular and cellular levels. The objectives of this review are to (1) discuss the clinical applications of fat grafting, (2) describe the cellular biology of fat and the optimization of fat graft preparation, (3) illustrate the significance of adipose-derived stem cells and the potentiality of fat cells, (4) highlight the clinical uses of adipose-derived stem cells, and (5) explore the current and future frontiers of the study of fat grafting. Although collaborative knowledge has increased exponentially, many of the biological mechanisms behind fat grafting are still unknown. Plastic surgeons are in a unique position to pioneer both the scientific and clinical frontiers of fat grafting and to ultimately further this technology for the benefit of our patients.</p>
</abstract>
<kwd-group>
<kwd>lipografting</kwd>
<kwd>fat injections</kwd>
<kwd>liposculpture</kwd>
<kwd>face</kwd>
<kwd>breast</kwd>
<kwd>cosmetic surgery</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Although the cellular and molecular mechanisms of autologous fat grafting are just beginning to be elucidated, the clinical use of fat grafting has been discussed in the literature for over 100 years. First described by Neuber in 1893 for filling a retracted scar at the infraorbital rim,<sup><xref ref-type="bibr" rid="bibr1-1090820X12455658">1</xref></sup> fat grafting has since been used all over the body in a wide spectrum of clinical applications. The well-accepted use of fat grafting in the face, in addition to the success of newer procedures in breast reconstruction and augmentation, makes the continued diversified uses of fat grafting a worthwhile avenue of exploration.</p>
<sec id="section1-1090820X12455658">
<title>The Biology of Adipose Tissue</title>
<p>Adipose tissue plays a central role in aging, metabolism, and homeostasis.<sup><xref ref-type="bibr" rid="bibr2-1090820X12455658">2</xref></sup> Derived from the mesenchyme, adipose tissue provides the largest contribution by volume to the connective tissue matrix and comprises the largest endocrine organ in the body.<sup><xref ref-type="bibr" rid="bibr3-1090820X12455658">3</xref></sup> It is a complex tissue composed of matrices of adipocytes interspersed with collagen fibers, stromal cells, adipose-derived stem cells (ADSC), and neurovascular structures.<sup><xref ref-type="bibr" rid="bibr4-1090820X12455658">4</xref>,<xref ref-type="bibr" rid="bibr5-1090820X12455658">5</xref></sup> Subcutaneous fat comprises 85% of all adipose tissue in the human body, with the remainder composed of visceral fat. Importantly, subcutaneous adipose tissue is the largest known reservoir of adult stem cells and frequently targeted for regenerative therapeutic purposes in plastic and reconstructive surgery.<sup><xref ref-type="bibr" rid="bibr6-1090820X12455658">6</xref><xref ref-type="bibr" rid="bibr7-1090820X12455658"/><xref ref-type="bibr" rid="bibr8-1090820X12455658"/><xref ref-type="bibr" rid="bibr9-1090820X12455658"/>-<xref ref-type="bibr" rid="bibr10-1090820X12455658">10</xref></sup></p>
<p>The central role of adipose tissue in a multitude of physiological processes, such as lipid storage, cushioning of organs, metabolic homeostasis, immune regulation, and angiogenesis, highlights its significance in a complex network of systems, general health, and longevity.<sup><xref ref-type="bibr" rid="bibr11-1090820X12455658">11</xref>,<xref ref-type="bibr" rid="bibr12-1090820X12455658">12</xref></sup> Among its major physiologic contributions are energy storage, thermoregulation, and the secretion of adipokines. Recently, adipose tissue has been shown to play a potentially critical role in human aging through the caloric restriction pathway that has demonstrated increased longevity and metabolic benefits with decreased caloric intake across many eukaryotic organisms.<sup><xref ref-type="bibr" rid="bibr13-1090820X12455658">13</xref><xref ref-type="bibr" rid="bibr14-1090820X12455658"/><xref ref-type="bibr" rid="bibr15-1090820X12455658"/><xref ref-type="bibr" rid="bibr16-1090820X12455658"/><xref ref-type="bibr" rid="bibr17-1090820X12455658"/>-<xref ref-type="bibr" rid="bibr18-1090820X12455658">18</xref></sup> In contrast, an excess of adipose tissue, often resulting in obesity, has proven to be associated with significant metabolic derangements. These include changes in insulin metabolism, triglyceride and cholesterol storage, and their subsequent impact on related end-organ function and possibly longevity.</p>
<p>Until very recently, subcutaneous adipose tissue in adult humans was thought to be solely composed of white adipose tissue (WAT). Brown adipose tissue (BAT) differs significantly from its white counterpart, in that it contains a high concentration of mitochondria and thus is exceedingly metabolically active. BAT, which serves a known role in thermogenesis, was initially thought to be present only in newborns.<sup><xref ref-type="bibr" rid="bibr19-1090820X12455658">19</xref></sup> The development of <sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG) positron emission tomography (PET) enabled the discovery of BAT in adult humans, although it is still thought to comprise less than 1% of all fat in the adult human population.<sup><xref ref-type="bibr" rid="bibr20-1090820X12455658">20</xref></sup> It has been hypothesized that the high metabolic activity of BAT may confer a protective role in metabolism and aging. Uncoupling protein UCP-1 has been discovered in BAT-specific expression, and its expression is hypothesized to distinguish WAT from BAT. The molecular biology and genetic development of brown fat is the subject of multiple ongoing investigations. Specifically, the conversion of WAT to BAT in adults is the focus of several studies with enormous potential metabolic benefits.</p>
</sec>
<sec id="section2-1090820X12455658">
<title>Fat Preparation for Grafting</title>
<p>A universally accepted method for the harvesting and preparation of adipose tissue for grafting purposes has not been established. Although there is extensive literature on fat preparation techniques, there remains a lack of consensus on a single standard method.<sup><xref ref-type="bibr" rid="bibr21-1090820X12455658">21</xref></sup> In general, the technique is composed of 3 steps: (1) the harvest of adipose tissue via small- or large-volume liposuction, (2) the preparation of fat, and (3) the injection into the recipient site. Many techniques have been used since the introduction of fat grafting in the late 1800s, but the most frequently used methodology is the Coleman technique described in the early 1990s.<sup><xref ref-type="bibr" rid="bibr22-1090820X12455658">22</xref></sup> The premise of Coleman’s technique is that methods involving straining, whisking, filtering, and washing, as well as high negative and positive pressure during harvest or injection, can lead to irreparable violation of the fragile adipose tissue. This trauma to transplanted cells is hypothesized to lead to a higher rate of graft failure. To circumvent these risks, the Coleman technique calls for the use of a 10-mL syringe with gentle hand-applied negative pressure in harvesting. The syringe is centrifuged for 2 to 3 minutes at 3000 rpm (800 <italic>g</italic>) to separate out debris and oils from the cellular fraction. After centrifugation, the harvested fat separates into 3 distinct layers: oil layer at the top, cellular fraction in the middle, and cellular debris and red blood cells at the bottom. The top oil portion is decanted, and packing is used to remove any remaining oil. The bottom layer, composed of debris and red blood cells, is drained, leaving the cellular fraction in the syringe. The cellular fraction, composed of adipocytes and stromal vascular cells, is then transferred to 1- to 3-mL syringes for injection. Injection into the recipient site is conducted using very small aliquots (0.1 mL) via small tunnels through recipient tissue, theoretically allowing direct communication with recipient tissue for graft neovascularization.</p>
<p>Since the dissemination of Coleman’s basic fat graft harvesting principles, many modifications have been proposed to further optimize fat grafting success. For example, one group removed the centrifugation step and instead used a washing and straining technique by placing the harvested tissue on gauze and leaving it to decant in open air after serial washes with lactated Ringers solution.<sup><xref ref-type="bibr" rid="bibr23-1090820X12455658">23</xref></sup> Another study described a method of fat processing by placing aspirated fat onto a sterile towel, allowing fluids and debris to be absorbed, then injecting without further manipulation, achieving yields similar to centrifugation.<sup><xref ref-type="bibr" rid="bibr24-1090820X12455658">24</xref></sup> Still others, such as many in our group at the University of Pennsylvania, serially pass aspirated fat on nonadherent pads to mechanically separate out fluid and debris, obviating the use of the centrifuge. Commercial lipoaspirate preparation techniques also have been recently developed in light of the resurgence in fat grafting popularity. Many technologies claim higher graft viability by maximizing the proportion of living cells injected and minimizing cell damage. Systems such as LipiVage (Genesis Biosystems, Lewisville, Texas), PureGraft (Cytori Therapeutics, San Diego, California) and Viafill (Lipose Corp, Maitland, Florida) report differing methods with reported improvements in fat grafting safety and reliability.<sup><xref ref-type="bibr" rid="bibr25-1090820X12455658">25</xref><xref ref-type="bibr" rid="bibr26-1090820X12455658"/>-<xref ref-type="bibr" rid="bibr27-1090820X12455658">27</xref></sup></p>
<p>A consensus study by Kaufman et al<sup><xref ref-type="bibr" rid="bibr28-1090820X12455658">28</xref></sup> reviewed the general trends among current practicing surgeons performing fat grafting and found no difference in outcomes between differing donor sites. In that meta-analysis report, the authors found that the abdomen was the most commonly used donor site, 54% used the Coleman technique for harvesting, 50% used centrifugation, and another 29% used a modified washing technique for purification. There was no difference in outcome with use of centrifugation. Most important, 87% of surgeons overcorrected during fat grafting to account for fat resorption, and 50% of surgeons subjectively believed that there was at least 50% resorption of fat grafts in all of their patients at 6 months. Despite differences in technique and donor sites, there were no appreciable differences in clinical outcomes.</p>
<p>Attempts at optimizing fat grafting success and reproducibility have identified several factors as potential significant contributors to the viability of grafted fat: injected cell viability, injected cell type (stem cells vs adipocytes), and exclusion of noxious factors from the prepared graft. As previously described, the traumatic effects of the purification process on adipose cells have been suggested to result in poor outcomes.<sup><xref ref-type="bibr" rid="bibr29-1090820X12455658">29</xref></sup> Proper purification prior to grafting has been hypothesized by some to be directly related to fat cell viability. For example, blood products remaining in the grafted tissue may not only serve as nutritional media for bacteria but can contain free radicals that lead to cell membrane injury and ultimately hematoma-induced necrosis.<sup><xref ref-type="bibr" rid="bibr30-1090820X12455658">30</xref></sup> However, not all investigators subscribe to these concepts. In fact, some have argued that most grafted cells die upon grafting, and the resulting graft is actually derived from stimulation of local cellular proliferation.<sup><xref ref-type="bibr" rid="bibr31-1090820X12455658">31</xref></sup> Moreover, it remains to be determined whether adipocytes, preadipocytes, ADSC, or other stem cells have the most significant contribution to the viability of grafted fat. Although many techniques have been described, there have been no meticulously controlled comparative trials to truly determine which method may be the most reliable. The vast literature remains conflicting, and it is unclear whether the irregularity of outcomes is due to differences in technique, patient clinical parameters, or more likely to a poor understanding of basic adipose tissue biology, including the molecular contribution of aging.</p>
</sec>
<sec id="section3-1090820X12455658">
<title>Clinical Applications of Fat Grafting</title>
<p>Although the biology of adipose tissue remains to be well defined molecularly, the clinical use of autologous fat grafting continues to expand. Fat grafting has been frequently used as an adjunct procedure in the treatment of facial aging and facial reconstruction. In both instances, there is a loss of subcutaneous facial volume that results in unfavorable changes in skin integrity and makes the underlying bony structure more prominent. Although rhytidectomy techniques address the facial skin envelope and underlying fascial layer, patients frequently require the additional volume for a more natural youthful transformation. Common sites of fat transfer for facial rejuvenation include those that atrophy with age, such as the periorbital region, malar region, marionette lines, prejowl sulcus, and lips.<sup><xref ref-type="bibr" rid="bibr32-1090820X12455658">32</xref></sup> In current practice, fat is harvested from the abdomen, hips, or flanks and injected in low volumes in a “string-of-pearls” distribution in the subcutaneous layer of the targeted region of the face. The vascularity of the face is thought to contribute to graft survival. It has been suggested that the greatest retention of fat transfer occurs when the fat is placed supramuscularly, further optimizing blood supply to the graft.</p>
<p>In instances of soft tissue reconstruction after facial trauma and in patients with congenital defects, the viability and sustainability of fat grafts have been used to significantly improve facial contour and to soften soft tissue scarring. Mild to moderate facial deficiencies can also be filled using intramuscular fat injections at atrophic regions in patients with Parry-Romberg syndrome or Treacher-Collins syndrome, with improved volume lasting at least 18 months postoperatively.<sup><xref ref-type="bibr" rid="bibr33-1090820X12455658">33</xref></sup> Avelar et al<sup><xref ref-type="bibr" rid="bibr34-1090820X12455658">34</xref></sup> postulate that there is an inherent regenerative potential in the lipostructure of fat that aids in tissue regeneration and remodeling, as suggested by improvement in painful scar contracture and nerve entrapment. Prior histologic studies cited by these authors suggest that the physical action of fat injection in addition to the presence of mesenchymal stem cells within adipose tissue facilitates local vasculogenesis and collagen deposition, possibly aiding tissue regeneration.<sup><xref ref-type="bibr" rid="bibr33-1090820X12455658">33</xref>,<xref ref-type="bibr" rid="bibr35-1090820X12455658">35</xref>,<xref ref-type="bibr" rid="bibr36-1090820X12455658">36</xref></sup> Clinically, this group has seen improved healing with fat grafting when applied to burns, chronic wounds, and postmastectomy pain syndrome.<sup><xref ref-type="bibr" rid="bibr35-1090820X12455658">35</xref>,<xref ref-type="bibr" rid="bibr37-1090820X12455658">37</xref>,<xref ref-type="bibr" rid="bibr38-1090820X12455658">38</xref></sup></p>
<p>The most currently active frontier for the application of fat grafting is in breast reconstruction and augmentation procedures. Initially denounced in 1987 by the American Society of Plastic and Reconstructive Surgeons (now the American Society of Plastic Surgeons) for the unproven theoretical risk of obscuring the detection of early breast cancer, the technique of fat grafting to the breast has since been quietly investigated by a multitude of surgeons and scientists in the international forum.<sup><xref ref-type="bibr" rid="bibr39-1090820X12455658">39</xref></sup> As highlighted in a landmark article by Coleman et al<sup><xref ref-type="bibr" rid="bibr39-1090820X12455658">39</xref></sup> in 2007, fat grafting can be performed successfully for patients with micromastia, tuberous breast deformities, Poland syndrome, breast reconstruction deformities, and postaugmentation deformities with no detrimental effects or limitations to radiographic surveillance for breast cancer, findings that have also been supported by subsequent investigators.<sup><xref ref-type="bibr" rid="bibr40-1090820X12455658">40</xref><xref ref-type="bibr" rid="bibr41-1090820X12455658"/><xref ref-type="bibr" rid="bibr42-1090820X12455658"/>-<xref ref-type="bibr" rid="bibr43-1090820X12455658">43</xref></sup></p>
<p>Although often described as an adjunct procedure to improve contouring of the reconstructed breast,<sup><xref ref-type="bibr" rid="bibr44-1090820X12455658">44</xref>,<xref ref-type="bibr" rid="bibr45-1090820X12455658">45</xref></sup> fat grafting is also emerging as potentially a stand-alone technique for breast reconstruction. The advent of breast conservation therapy in the treatment of breast cancer, often with necessary postoperative radiation, has introduced a new set of reconstructive goals. Advocates of lipofilling of partial mastectomy and lumpectomy defects have demonstrated improved contouring and aesthetic results with this minimally-invasive technique.<sup><xref ref-type="bibr" rid="bibr43-1090820X12455658">43</xref><xref ref-type="bibr" rid="bibr44-1090820X12455658"/>-<xref ref-type="bibr" rid="bibr45-1090820X12455658">45</xref></sup> For patients who have already undergone autologous reconstruction, fat transfer can be used not only for improving contour, but also for increasing volume instead of or in addition to implants. This technique of fat grafting has been used with success in the latissimus dorsi flap, a pedicled flap for breast reconstruction that frequently needs an expander or implant to achieve adequate breast volume.<sup><xref ref-type="bibr" rid="bibr46-1090820X12455658">46</xref></sup> In one published study, an average of 175 mL of harvested fat was injected in the subcutaneous tissue, pectoral muscle, and the latissimus muscle itself in 200 patients who had undergone a pedicled latissimus flap procedure, with a 30% to 40% resorption rate, but stable breast projection and fullness an average of 14 months after injection.<sup><xref ref-type="bibr" rid="bibr46-1090820X12455658">46</xref></sup> Interestingly, this technique of moderate-volume fat grafting in or around a muscle bed has also been used as an adjunct procedure to decrease complication rates of implant reconstruction in irradiated patients with poor tissue integrity secondary to radiation therapy.<sup><xref ref-type="bibr" rid="bibr47-1090820X12455658">47</xref></sup> Fat harvesting and grafting to the pectoralis commenced an average of 6 months after radiation was completed, and most patients needed at least 2 sessions of fat grafting, each with a mean injection volume of 115 mL for adequate soft tissue thickness and coverage prior to implant placement.<sup><xref ref-type="bibr" rid="bibr47-1090820X12455658">47</xref></sup> There was only a 3% rate of implant loss, as compared with a 15% rate of implant extrusion in irradiated patients in the literature.<sup><xref ref-type="bibr" rid="bibr47-1090820X12455658">47</xref></sup></p>
<p>The success of moderate-volume fat transfer has paved the way for the potential use of larger volume fat grafting alone in breast reconstruction. In patients with complications after implant reconstruction necessitating the removal of the implant, small-volume fat injections can be used to first soften fibrotic scarring, with subsequent increases in injected volumes, for a total of 700 mL transferred over the course of 13.5 months in 1 patient<sup><xref ref-type="bibr" rid="bibr48-1090820X12455658">48</xref></sup> and a total of 1500 mL transferred over the course of 4 years in another.<sup><xref ref-type="bibr" rid="bibr49-1090820X12455658">49</xref></sup> This method has demonstrated the accumulation of serial intrinsic expansion using fat grafting, with a total graft survival rate greater than 60%.<sup><xref ref-type="bibr" rid="bibr48-1090820X12455658">48</xref></sup> Other investigators have advocated for the use of BRAVA, an external preexpansion device, prior to the injection of large volumes of fat into the breast.<sup><xref ref-type="bibr" rid="bibr40-1090820X12455658">40</xref>,<xref ref-type="bibr" rid="bibr50-1090820X12455658">50</xref></sup> At 6 months postoperatively, a series involving 12 patients who had undergone large-volume fat grafting demonstrated a more than 100% increase in volume by magnetic resonance imaging (MRI).<sup><xref ref-type="bibr" rid="bibr40-1090820X12455658">40</xref></sup> The authors postulate that the micromechanical forces of external expansion, coupled with an augmented parenchymal space for fat placement, both increase graft survival through angiogenesis and decrease the ischemic effects of compression and graft crowding, resulting in the success of large-volume fat transfers.<sup><xref ref-type="bibr" rid="bibr40-1090820X12455658">40</xref></sup></p>
</sec>
<sec id="section4-1090820X12455658">
<title>Adipose-Derived Stem Cells</title>
<p>A breakthrough in both soft tissue regeneration and stem cell research occurred with the discovery of ADSC.<sup><xref ref-type="bibr" rid="bibr51-1090820X12455658">51</xref></sup> Since then, ADSC have been characterized as a type of mesenchymal stem cell with the ability to differentiate into a multitude of tissues with angiogenic potential via endothelial neovascularization.<sup><xref ref-type="bibr" rid="bibr25-1090820X12455658">25</xref></sup> The isolation of ADSC is composed of 4 main steps: (1) harvest of lipoaspirate or excised fat, (2) processing in fat in collagenase solution, (3) centrifugation to separate out the stromal vascular fraction which contains the stem cells, and (4) culture and expansion of the isolated stem cell line after flow cytometry analysis. Given their regenerative potential, ADSC are being investigated for multiple types of neovascularized tissue reconstructions. However, to make a successful transition from stem cell isolation to soft tissue reconstruction, the pathways of ADSC growth and differentiation must be defined at the molecular level.</p>
<p>Stem cells are defined by the ability to undergo multiple divisions without differentiation as well as the ability to differentiate into multiple lineages. Embryonic stem cells are derived from the inner cell mass of the blastocyst and are totipotent, meaning they can differentiate into any cell type. In contrast, adult stem cells are multipotent and thus can differentiate into many (but not all) cell types. ADSC can differentiate into multiple cell types, including adipocytes, cardiomyocytes, chondrocytes, endothelial cells, myocytes, neuronal-like cells, and osteoblasts. Significantly, ADSC have been shown to represent a heterogeneous group of stem cells that express variable cell markers. Controversy remains over the differences in molecular phenotype. Recently, CD 34+/CD45– cells have been proposed to have the most adipogenic potential.<sup><xref ref-type="bibr" rid="bibr26-1090820X12455658">26</xref></sup> Many cell types, including pericytes, adipose tissue fibroblasts, and macrophages, have been proposed as ADSC precursors.<sup><xref ref-type="bibr" rid="bibr27-1090820X12455658">27</xref>,<xref ref-type="bibr" rid="bibr52-1090820X12455658">52</xref><xref ref-type="bibr" rid="bibr53-1090820X12455658"/>-<xref ref-type="bibr" rid="bibr54-1090820X12455658">54</xref></sup> The specific lineage of origin of ADSC, however, has yet to be determined, and its identification may lead to a better understanding of their potential applications for reconstruction.<sup><xref ref-type="bibr" rid="bibr25-1090820X12455658">25</xref></sup></p>
<p>The potential for ADSC to differentiate into endothelial cells has generated numerous investigations into their potential for neovascularization of soft tissue reconstruction. Larger fat grafts are thought to be limited by poor diffusion of nutrients and oxygen from inadequate vascular networks.<sup><xref ref-type="bibr" rid="bibr55-1090820X12455658">55</xref></sup> A model by Kang et al<sup><xref ref-type="bibr" rid="bibr56-1090820X12455658">56</xref></sup> examined the contribution of ADSC to neoangiogenesis generated endothelial lumens on 3-dimensional adipose tissue constructs harboring ADSC and human umbilical vein endothelial cells on a silk protein scaffold. Although many studies are investigating the role of embryonic stem cells and adult human fibroblasts for the formation of neovessels, the accessibility and abundance of ADSCs may make these cells ultimately better candidates for vascular engineering applications.<sup><xref ref-type="bibr" rid="bibr55-1090820X12455658">55</xref>,<xref ref-type="bibr" rid="bibr57-1090820X12455658">57</xref>,<xref ref-type="bibr" rid="bibr58-1090820X12455658">58</xref></sup></p>
<p>Another important concept in the biology of ADSCs is the “seed vs soil” basis of tissue engineering. Described in a number of studies, this model suggests that tissue engineering relies not only on the isolated donor cells as building blocks but also on the recipient matrix and support substrates that create the proper biochemical environment for growth.<sup><xref ref-type="bibr" rid="bibr59-1090820X12455658">59</xref>,<xref ref-type="bibr" rid="bibr60-1090820X12455658">60</xref></sup> Many studies have investigated matrices and scaffolds, as well as the biologic nutrients, or “soil,” needed for successful tissue engineering. Scaffolds treated with multiple cellular components and enzymes such as trypsin and collagenase were found to create distinct structures and compositions, and yet all supported adipogenic differentiation. Synthetic polymers such as polylactic acid (PLA), polyglycolic acid (PGA), and poly(lactic-co-glycolic acid) (PLGA) have been used extensively in adipose tissue engineering studies and show great promise in supporting growth. Other synthetic polymers such as hydrogels made of polyethylene glycol and silicone may also have a positive contribution.<sup><xref ref-type="bibr" rid="bibr55-1090820X12455658">55</xref></sup> Natural polymers such as collagen, gelatin, and silk are of even greater interest secondary to unparalleled biocompatibility and safety. A study comparing the longevity of collagen, silk, and PLA scaffolds found that silk degraded significantly more slowly than collagen or PLA, suggesting it may be more promising in cultivating ADSC graft viability and longevity.<sup><xref ref-type="bibr" rid="bibr19-1090820X12455658">19</xref></sup></p>
<p>Finally, the role of different culture media types on ADSC growth has also been examined. Fetal calf serum was found to increase cell proliferation, whereas human serum improved cellular differentiation. Fibronectin increased viability of preadipocytes and improved their differentiation into mature adipocytes.<sup><xref ref-type="bibr" rid="bibr61-1090820X12455658">61</xref></sup> Interestingly, the overexpression of estrogen sulfotransferase in the white adipose tissue of mice prevented adipocyte differentiation by inhibiting insulin signaling, whereas its repression resulted in the inability to inhibit differentiation.<sup><xref ref-type="bibr" rid="bibr62-1090820X12455658">62</xref></sup> The exact role of estrogen sulfotransferase on human ADSC has yet to be determined.<sup><xref ref-type="bibr" rid="bibr62-1090820X12455658">62</xref></sup></p>
</sec>
<sec id="section5-1090820X12455658">
<title>Clinical Applications of Adipose-Derived Stem Cells</title>
<p>Because ADSCs are considered the main regenerative component of adipose tissue, scientists have begun not only to investigate the stem cell–based molecular mechanisms optimizing the viability of fat grafts but also to explore additional potential clinical applications.<sup><xref ref-type="bibr" rid="bibr33-1090820X12455658">33</xref>,<xref ref-type="bibr" rid="bibr36-1090820X12455658">36</xref>,<xref ref-type="bibr" rid="bibr63-1090820X12455658">63</xref></sup> For example, patients who have had radiation necrosis of soft tissue and bone have also exhibited symptomatic and cosmetic improvement with the grafting of lipoaspirate shown to specifically contain adipose-derived stem cells.<sup><xref ref-type="bibr" rid="bibr36-1090820X12455658">36</xref></sup> Matsumoto et al<sup><xref ref-type="bibr" rid="bibr63-1090820X12455658">63</xref></sup> have developed a method of concentrating ADSC from lipoaspirate, hypothetically increasing the percentage of viable stem cells per volume of structural adipose tissue grafted. Their studies have shown a sustained increase in soft tissue augmentation when the lipoaspirate is enriched with ADSCs and injected into the subcutaneous, supramuscular, and muscular layers of the face and breast.<sup><xref ref-type="bibr" rid="bibr63-1090820X12455658">63</xref><xref ref-type="bibr" rid="bibr64-1090820X12455658"/>-<xref ref-type="bibr" rid="bibr65-1090820X12455658">65</xref></sup> Although their findings are promising, these authors acknowledge the need for future comparisons to control groups and longer follow-up periods to demonstrate statistically significant results.<sup><xref ref-type="bibr" rid="bibr63-1090820X12455658">63</xref><xref ref-type="bibr" rid="bibr64-1090820X12455658"/>-<xref ref-type="bibr" rid="bibr65-1090820X12455658">65</xref></sup></p>
<p>Encouraging results also have been observed when adipose-derived stem cells are used for the regeneration of tissue types other than fat.<sup><xref ref-type="bibr" rid="bibr33-1090820X12455658">33</xref></sup> In a rat model of facial nerve injury, Sun et al<sup><xref ref-type="bibr" rid="bibr66-1090820X12455658">66</xref></sup> have demonstrated neural regeneration using ADSCs in a decellularized arterial conduit with axonal growth and myelin formation 8 weeks postoperatively. When injected in the underlying fascial layer in a rat model of skin grafting, ADSCs have also contributed to increasing skin graft viability as early as 1 week postoperatively.<sup><xref ref-type="bibr" rid="bibr67-1090820X12455658">67</xref></sup> In patients with avascular necrosis of the femoral head and meniscus cartilage degeneration in the knee, pilot studies have shown that injecting adipose-derived stem cells mixed with platelet-rich plasma, hyaluronic acid, and calcium chloride directly into the hip and knee results in visible filling of bony and cartilaginous defects on MRI by 12 weeks postinjection with symptomatic improvement in mobility.<sup><xref ref-type="bibr" rid="bibr68-1090820X12455658">68</xref></sup> Perhaps even more impressively, Shi et al<sup><xref ref-type="bibr" rid="bibr69-1090820X12455658">69</xref></sup> have programmed ADSCs to upregulate endothelial nitric oxide expression in a rat model of myocardial infarction, resulting in smaller infarct sizes and increased angiogenesis by histologic analysis.</p>
<p>With the expanding interest in clinical fat grafting applications and the focus on the regenerative medicine therapeutic potential of ADSCs, it is necessary to elucidate the molecular mechanisms responsible for fat graft viability and ADSC biology. Thus far, the success and reliability of fat grafting and related applications, although promising, continue to be limited and unpredictable, largely secondary to these gaps in knowledge.</p>
</sec>
<sec id="section6-1090820X12455658">
<title>Dedifferentiated Fat Cells</title>
<p>Recently, a potential alternative source to ADSC in adipose tissue has been discovered through dedifferentiation of adipocytes and merits further discussion.<sup><xref ref-type="bibr" rid="bibr6-1090820X12455658">6</xref></sup> Due to significant buoyancy, mature adipocytes are easily isolated using a modified ceiling culture technique in which adipocytes float to the surface of a flask and adhere to the ceiling. Over 2 to 3 weeks, the fat drops slowly disappear and are replaced by fibroblast-like cells with multipotent morphology. The cells are then referred to as dedifferentiated fat cells (DFAT), which are more homogeneous in morphology than their ADSC counterparts. DFATs are capable of differentiating into multiple lineages, including adipocytes, chondrocytes, and osteocytes. The mechanism of the dedifferentiation process is unclear but is thought to be related to a hypoxic environment. Additional studies are needed to understand the biologic potential of this novel cellular population.</p>
</sec>
<sec id="section7-1090820X12455658">
<title>Future of Fat Grafting</title>
<p>The future of fat grafting technologies and clinical applications have been extensively discussed at recent national meetings. At the 2011 International Federation for Adipose Therapeutics and Science (IFATS) annual meeting, scientists and clinicians presented the latest advancements in this field. Investigators have reported the safety and successful retention of adjunctive fat grafting during breast augmentation.<sup><xref ref-type="bibr" rid="bibr70-1090820X12455658">70</xref></sup> Others have described the use of 3-dimensional imaging technology in evaluating the retention of volume of fat grafting in breast reconstruction, finding that approximately half of the volume in large-volume fat grafting remains 2 months postoperatively.<sup><xref ref-type="bibr" rid="bibr71-1090820X12455658">71</xref></sup> In molecular studies, it has been further demonstrated that increasing the concentration of adipose-derived stem cells increases fat graft viability, with less fibrosis, oily cyst formation, and inflammatory infiltrate.<sup><xref ref-type="bibr" rid="bibr72-1090820X12455658">72</xref></sup> Other authors reported their experience with commercial devices used for the extraction of stromal vascular cells from lipoaspirate, describing similar efficacy but with variable costs.<sup><xref ref-type="bibr" rid="bibr73-1090820X12455658">73</xref></sup> In addition, at the 2011 Cutting Edge Aesthetic Surgery Symposium (December 1-3, 2011, New York, NY), there were sessions specifically focused on recent advancements in fat grafting techniques and putative novel applications.<sup><xref ref-type="bibr" rid="bibr74-1090820X12455658">74</xref></sup></p>
</sec>
<sec id="section8-1090820X12455658">
<title>Conclusions</title>
<p>The field of autologous fat grafting has enormous promise clinically and scientifically. Initially applied to scar recontouring in the late 19th century, fat grafting has since been successfully used as an adjunct volumizing technique with expansion into other aspects of soft tissue rejuvenation and reconstruction. Despite a recent international resurgence in fat grafting popularity, the limitations of autologous fat transfer remain ever present: unpredictable reliability and viability of grafted fat, disagreement over the optimal fat preparation technique and recipient site preparation, and the significance of ADSCs and other progenitor cells to the successful survival of grafts.<sup><xref ref-type="bibr" rid="bibr55-1090820X12455658">55</xref></sup> Significant advances in ADSC-based therapies have propelled the field of fat grafting into the limelight of regenerative medicine. Yet, until we gain a better understanding of the complex molecular regulatory mechanisms controlling adipose tissue and ADSC biology, we will not be able to fully harvest the true potential of autologous fat.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Disclosures</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1090820X12455658">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Van de Graaf</surname><given-names>RAK</given-names></name>
</person-group>. <article-title>SFS, Gustav Adolf Neuber (1850-1932) and the first report on fat auto-grafting in humans in 1893</article-title>. <source>J Hist Plast Surg</source>. <year>2010</year>;<volume>1</volume>(<issue>1</issue>):<fpage>7</fpage>-<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr2-1090820X12455658">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lafontan</surname><given-names>M</given-names></name>
</person-group>. <article-title>Historical perspectives in fat cell biology: the fat cell as a model for the investigation of hormonal and metabolic pathways</article-title>. <source>Am J Physiol Cell Physiol</source>. <year>2012</year>;<volume>302</volume>:<fpage>C327</fpage>-<lpage>C359</lpage>.</citation>
</ref>
<ref id="bibr3-1090820X12455658">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Laharrague</surname><given-names>P</given-names></name>
<name><surname>Casteilla</surname><given-names>L</given-names></name>
</person-group>. <article-title>The emergence of adipocytes</article-title>. <source>Endocr Dev</source>. <year>2010</year>;<volume>19</volume>:<fpage>21</fpage>-<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr4-1090820X12455658">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bai</surname><given-names>X</given-names></name>
<name><surname>Alt</surname><given-names>E</given-names></name>
</person-group>. <article-title>Myocardial regeneration potential of adipose tissue-derived stem cells</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2010</year>;<volume>401</volume>(<issue>3</issue>):<fpage>321</fpage>-<lpage>326</lpage>.</citation>
</ref>
<ref id="bibr5-1090820X12455658">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vaquero</surname><given-names>A</given-names></name>
<name><surname>Sternglanz</surname><given-names>R</given-names></name>
<name><surname>Reinberg</surname><given-names>D</given-names></name>
</person-group>. <article-title>NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs</article-title>. <source>Oncogene</source>. <year>2007</year>;<volume>26</volume>(<issue>37</issue>):<fpage>5505</fpage>-<lpage>5520</lpage>.</citation>
</ref>
<ref id="bibr6-1090820X12455658">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shen</surname><given-names>JEA</given-names></name>
</person-group>. <article-title>Dedifferentiated fat cells: an alternative source of adult mulitpotent cells from the adipose tissues</article-title>. <source>Int J Oral Sci</source>. <year>2011</year>;<volume>3</volume>(<issue>3</issue>):<fpage>117</fpage>-<lpage>124</lpage>.</citation>
</ref>
<ref id="bibr7-1090820X12455658">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zuk</surname><given-names>PA</given-names></name>
</person-group>. <article-title>The adipose-derived stem cell: looking back and looking ahead</article-title>. <source>Mol Biol Cell</source>. <year>2010</year>;<volume>21</volume>(<issue>11</issue>):<fpage>1783</fpage>-<lpage>1787</lpage>.</citation>
</ref>
<ref id="bibr8-1090820X12455658">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Behr</surname><given-names>B</given-names></name>
<name><surname>Tang</surname><given-names>C</given-names></name>
<name><surname>Germann</surname><given-names>G</given-names></name>
<name><surname>Longaker</surname><given-names>MT</given-names></name>
<name><surname>Quarto</surname><given-names>N</given-names></name>
</person-group>. <article-title>Locally applied vascular endothelial growth factor A increases the osteogenic healing capacity of human adipose derived stem cells by promoting osteogenic and endothelial differentiation</article-title>. <source>Stem Cells</source>. <year>2011</year>;<volume>29</volume>(<issue>2</issue>):<fpage>286</fpage>-<lpage>296</lpage>.</citation>
</ref>
<ref id="bibr9-1090820X12455658">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sylvester</surname><given-names>KG</given-names></name>
<name><surname>Longaker</surname><given-names>MT</given-names></name>
</person-group>. <article-title>Stem cells: review and update</article-title>. <source>Arch Surg</source>. <year>2004</year>;<volume>139</volume>(<issue>1</issue>):<fpage>93</fpage>-<lpage>99</lpage>.</citation>
</ref>
<ref id="bibr10-1090820X12455658">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brayfield</surname><given-names>CA</given-names></name>
<name><surname>Marra</surname><given-names>KG</given-names></name>
<name><surname>Rubin</surname><given-names>JP</given-names></name>
</person-group>. <article-title>Adipose tissue regeneration</article-title>. <source>Curr Stem Cell Res Ther</source>. <year>2010</year>;<volume>5</volume>(<issue>2</issue>):<fpage>116</fpage>-<lpage>121</lpage>.</citation>
</ref>
<ref id="bibr11-1090820X12455658">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Haque</surname><given-names>WA</given-names></name>
<name><surname>Garg</surname><given-names>A</given-names></name>
</person-group>. <article-title>Adipocyte biology and adipocytokines</article-title>. <source>Clin Lab Med</source>. <year>2004</year>;<volume>24</volume>(<issue>1</issue>):<fpage>217</fpage>-<lpage>234</lpage>.</citation>
</ref>
<ref id="bibr12-1090820X12455658">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rosen</surname><given-names>ED</given-names></name>
<name><surname>Spiegelman</surname><given-names>BM</given-names></name>
</person-group>. <article-title>Adipocytes as regulators of energy balance and glucose homeostasis</article-title>. <source>Nature</source>. <year>2006</year>;<volume>444</volume>(<issue>7121</issue>):<fpage>847</fpage>-<lpage>853</lpage>.</citation>
</ref>
<ref id="bibr13-1090820X12455658">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oberdoerffer</surname><given-names>P</given-names></name>
<name><surname>Michan</surname><given-names>S</given-names></name>
<name><surname>McVay</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging</article-title>. <source>Cell</source>. <year>2008</year>;<volume>135</volume>(<issue>5</issue>):<fpage>907</fpage>-<lpage>918</lpage>.</citation>
</ref>
<ref id="bibr14-1090820X12455658">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Agarwal</surname><given-names>B</given-names></name>
<name><surname>Baur</surname><given-names>JA</given-names></name>
</person-group>. <article-title>Resveratrol and life extension</article-title>. <source>Ann N Y Acad Sci</source>. <year>2011</year>;<volume>1215</volume>:<fpage>138</fpage>-<lpage>143</lpage>.</citation>
</ref>
<ref id="bibr15-1090820X12455658">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guarente</surname><given-names>L</given-names></name>
<name><surname>Franklin</surname><given-names>H</given-names></name>
</person-group>. <article-title>Epstein lecture: sirtuins, aging, and medicine</article-title>. <source>N Engl J Med</source>. <year>2011</year>;<volume>364</volume>(<issue>23</issue>):<fpage>2235</fpage>-<lpage>2244</lpage>.</citation>
</ref>
<ref id="bibr16-1090820X12455658">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smith</surname><given-names>DL</given-names><suffix>Jr</suffix></name>
<name><surname>Nagy</surname><given-names>TR</given-names></name>
<name><surname>Allison</surname><given-names>DB</given-names></name>
</person-group>. <article-title>Calorie restriction: what recent results suggest for the future of ageing research</article-title>. <source>Eur J Clin Invest</source>. <year>2010</year>;<volume>40</volume>(<issue>5</issue>):<fpage>440</fpage>-<lpage>450</lpage>.</citation>
</ref>
<ref id="bibr17-1090820X12455658">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Picard</surname><given-names>F</given-names></name>
<name><surname>Guarente</surname><given-names>L</given-names></name>
</person-group>. <article-title>Molecular links between aging and adipose tissue</article-title>. <source>Int J Obes (Lond)</source>. <year>2005</year>;<volume>29</volume>(<supplement>suppl 1</supplement>):<fpage>S36</fpage>-<lpage>S39</lpage>.</citation>
</ref>
<ref id="bibr18-1090820X12455658">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kennedy</surname><given-names>BK</given-names></name>
<name><surname>Steffen</surname><given-names>KK</given-names></name>
<name><surname>Kaeberlein</surname><given-names>M</given-names></name>
</person-group>. <article-title>Ruminations on dietary restriction and aging</article-title>. <source>Cell Mol Life Sci</source>. <year>2007</year>;<volume>64</volume>(<issue>11</issue>):<fpage>1323</fpage>-<lpage>1328</lpage>.</citation>
</ref>
<ref id="bibr19-1090820X12455658">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mauney</surname><given-names>JR</given-names></name>
<name><surname>Nguyen</surname><given-names>T</given-names></name>
<name><surname>Gillen</surname><given-names>K</given-names></name>
<name><surname>Kirker-Head</surname><given-names>C</given-names></name>
<name><surname>Gimble</surname><given-names>JM</given-names></name>
<name><surname>Kaplan</surname><given-names>DL</given-names></name>
</person-group>. <article-title>Engineering adipose-like tissue in vitro and in vivo utilizing human bone marrow and adipose-derived mesenchymal stem cells with silk fibroin 3D scaffolds</article-title>. <source>Biomaterials</source>. <year>2007</year>;<volume>28</volume>(<issue>35</issue>):<fpage>5280</fpage>-<lpage>5290</lpage>.</citation>
</ref>
<ref id="bibr20-1090820X12455658">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nedergaard</surname><given-names>J</given-names></name>
<name><surname>Bengtsson</surname><given-names>T</given-names></name>
<name><surname>Cannon</surname><given-names>B</given-names></name>
</person-group>. <article-title>Three years with adult human brown adipose tissue</article-title>. <source>Ann N Y Acad Sci</source>. <year>2010</year>;<volume>1212</volume>:<fpage>E20</fpage>-<lpage>E36</lpage>.</citation>
</ref>
<ref id="bibr21-1090820X12455658">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bucky</surname><given-names>LP</given-names></name>
<name><surname>Percec</surname><given-names>I</given-names></name>
</person-group>. <article-title>The science of autologous fat grafting: views on current and future approaches to neoadipogenesis</article-title>. <source>Aesthetic Surg J</source>. <year>2008</year>;<volume>28</volume>(<issue>3</issue>):<fpage>313</fpage>-<lpage>321</lpage>; <comment>quiz 322-324</comment>.</citation>
</ref>
<ref id="bibr22-1090820X12455658">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Coleman</surname><given-names>S</given-names></name>
</person-group>. <article-title>Facial recontouring with lipostructure</article-title>. <source>Clin Plast Surg</source>. <year>1997</year>;<volume>24</volume>(<issue>2</issue>):<fpage>347</fpage>-<lpage>367</lpage>.</citation>
</ref>
<ref id="bibr23-1090820X12455658">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuran</surname><given-names>I</given-names></name>
<name><surname>Tumerdem</surname><given-names>B</given-names></name>
</person-group>. <article-title>A new simple method used to prepare fat for injection</article-title>. <source>Aesthetic Plast Surg</source>. <year>2005</year>;<volume>29</volume>(<issue>1</issue>):<fpage>18</fpage>-<lpage>22</lpage>; <comment>discussion 23</comment>.</citation>
</ref>
<ref id="bibr24-1090820X12455658">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ramon</surname><given-names>Y</given-names></name>
<name><surname>Shoshani</surname><given-names>O</given-names></name>
<name><surname>Peled</surname><given-names>IJ</given-names></name>
<etal/>
</person-group>. <article-title>Enhancing the take of injected adipose tissue by a simple method for concentrating fat cells</article-title>. <source>Plast Reconstr Surg</source>. <year>2005</year>;<volume>115</volume>(<issue>1</issue>):<fpage>197</fpage>-<lpage>201</lpage>; <comment>discussion 202-203</comment>.</citation>
</ref>
<ref id="bibr25-1090820X12455658">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brown</surname><given-names>SA</given-names></name>
<name><surname>Levi</surname><given-names>B</given-names></name>
<name><surname>Lequeux</surname><given-names>C</given-names></name>
<name><surname>Wong</surname><given-names>VW</given-names></name>
<name><surname>Mojallal</surname><given-names>A</given-names></name>
<name><surname>Longaker</surname><given-names>MT</given-names></name>
</person-group>. <article-title>Basic science review on adipose tissue for clinicians</article-title>. <source>Plast Reconstr Surg</source>. <year>2010</year>;<volume>126</volume>(<issue>6</issue>):<fpage>1936</fpage>-<lpage>1946</lpage>.</citation>
</ref>
<ref id="bibr26-1090820X12455658">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>H</given-names></name>
<name><surname>Zimmerlin</surname><given-names>L</given-names></name>
<name><surname>Marra</surname><given-names>KG</given-names></name>
<name><surname>Donnenberg</surname><given-names>VS</given-names></name>
<name><surname>Donnenberg</surname><given-names>AD</given-names></name>
<name><surname>Rubin</surname><given-names>JP</given-names></name>
</person-group>. <article-title>Adipogenic potential of adipose stem cell subpopulations</article-title>. <source>Plast Reconstr Surg</source>. <year>2011</year>;<volume>128</volume>(<issue>3</issue>):<fpage>663</fpage>-<lpage>672</lpage>.</citation>
</ref>
<ref id="bibr27-1090820X12455658">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chazenbalk</surname><given-names>G</given-names></name>
<name><surname>Bertolotto</surname><given-names>C</given-names></name>
<name><surname>Heneidi</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Novel pathway of adipogenesis through cross-talk between adipose tissue macrophages, adipose stem cells and adipocytes: evidence of cell plasticity</article-title>. <source>PLoS One</source>. <year>2011</year>;<volume>6</volume>(<issue>3</issue>):<fpage>e17834</fpage>.</citation>
</ref>
<ref id="bibr28-1090820X12455658">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaufman</surname><given-names>MR</given-names></name>
<name><surname>Bradley</surname><given-names>JP</given-names></name>
<name><surname>Dickinson</surname><given-names>B</given-names></name>
<etal/>
</person-group>. <article-title>Autologous fat transfer national consensus survey: trends in techniques for harvest, preparation, and application, and perception of short- and long-term results</article-title>. <source>Plast Reconstr Surg</source>. <year>2007</year>;<volume>119</volume>(<issue>1</issue>):<fpage>323</fpage>-<lpage>331</lpage>.</citation>
</ref>
<ref id="bibr29-1090820X12455658">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Campbell</surname><given-names>G</given-names></name>
<name><surname>Laudenslagter</surname><given-names>N</given-names></name>
<name><surname>Newman</surname><given-names>J</given-names></name>
</person-group>. <article-title>The effect of mechanical stress on adipocyte morphology and metabolism</article-title>. <source>Am J Cosmet Surg</source>. <year>1987</year>;<volume>4</volume>:<fpage>89</fpage>-<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr30-1090820X12455658">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Karacalar</surname><given-names>A</given-names></name>
<name><surname>Orak</surname><given-names>I</given-names></name>
<name><surname>Kaplan</surname><given-names>S</given-names></name>
<name><surname>Yildirim</surname><given-names>S</given-names></name>
</person-group>. <article-title>No-touch technique for autologous fat harvesting</article-title>. <source>Aesthetic Plast Surg</source>. <year>2004</year>;<volume>28</volume>(<issue>3</issue>):<fpage>158</fpage>-<lpage>164</lpage>.</citation>
</ref>
<ref id="bibr31-1090820X12455658">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshimura</surname><given-names>K</given-names></name>
<name><surname>Suga</surname><given-names>H</given-names></name>
<name><surname>Eto</surname><given-names>H</given-names></name>
</person-group>. <article-title>Adipose-derived stem/progenitor cells: roles in adipose tissue remodeling and potential use for soft tissue augmentation</article-title>. <source>Regen Med</source>. <year>2009</year>;<volume>4</volume>(<issue>2</issue>):<fpage>265</fpage>-<lpage>273</lpage>.</citation>
</ref>
<ref id="bibr32-1090820X12455658">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Glasgold</surname><given-names>RA</given-names></name>
<name><surname>Lam</surname><given-names>SM</given-names></name>
<name><surname>Glasgold</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Facial fat grafting: the new paradigm</article-title>. <source>Arch Facial Plast Surg</source>. <year>2008</year>;<volume>10</volume>(<issue>6</issue>):<fpage>417</fpage>-<lpage>418</lpage>.</citation>
</ref>
<ref id="bibr33-1090820X12455658">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beeson</surname><given-names>W</given-names></name>
<name><surname>Woods</surname><given-names>E</given-names></name>
<name><surname>Agha</surname><given-names>R</given-names></name>
</person-group>. <article-title>Tissue engineering, regenerative medicine, and rejuvenation in 2010: the role of adipose-derived stem cells</article-title>. <source>Facial Plast Surg</source>. <year>2011</year>;<volume>27</volume>(<issue>4</issue>):<fpage>378</fpage>-<lpage>387</lpage>.</citation>
</ref>
<ref id="bibr34-1090820X12455658">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Avelar</surname><given-names>RL</given-names></name>
<name><surname>Göelzer</surname><given-names>JG</given-names></name>
<name><surname>Azambuja</surname><given-names>FG</given-names></name>
<name><surname>de Oliveira</surname><given-names>RB</given-names></name>
<name><surname>de Oliveira</surname><given-names>MP</given-names></name>
<name><surname>Pase</surname><given-names>PF</given-names></name>
</person-group>. <article-title>Use of autologous fat graft for correction of facial asymmetry stemming from Parry-Romberg syndrome</article-title>. <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>. <year>2010</year>;<volume>109</volume>(<issue>2</issue>):<fpage>e20</fpage>-<lpage>e25</lpage>.</citation>
</ref>
<ref id="bibr35-1090820X12455658">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Caviggioli</surname><given-names>F</given-names></name>
<name><surname>Maione</surname><given-names>L</given-names></name>
<name><surname>Forcellini</surname><given-names>D</given-names></name>
<name><surname>Klinger</surname><given-names>F</given-names></name>
<name><surname>Klinger</surname><given-names>M</given-names></name>
</person-group>. <article-title>Autologous fat graft in postmastectomy pain syndrome</article-title>. <source>Plast Reconstr Surg</source>. <year>2011</year>;<volume>128</volume>(<issue>2</issue>):<fpage>349</fpage>-<lpage>352</lpage>.</citation>
</ref>
<ref id="bibr36-1090820X12455658">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rigotti</surname><given-names>G</given-names></name>
<name><surname>Marchi</surname><given-names>A</given-names></name>
<name><surname>Galiè</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells</article-title>. <source>Plast Reconstr Surg</source>. <year>2007</year>;<volume>119</volume>(<issue>5</issue>):<fpage>1409</fpage>-<lpage>1422</lpage>; <comment>discussion 1423-1424</comment>.</citation>
</ref>
<ref id="bibr37-1090820X12455658">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Klinger</surname><given-names>M</given-names></name>
<name><surname>Marazzi</surname><given-names>M</given-names></name>
<name><surname>Vigo</surname><given-names>D</given-names></name>
<name><surname>Torre</surname><given-names>M</given-names></name>
</person-group>. <article-title>Fat injection for cases of severe burn outcomes: a new perspective of scar remodeling and reduction</article-title>. <source>Aesthetic Plast Surg</source>. <year>2008</year>;<volume>32</volume>(<issue>3</issue>):<fpage>465</fpage>-<lpage>469</lpage>.</citation>
</ref>
<ref id="bibr38-1090820X12455658">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Caviggioli</surname><given-names>F</given-names></name>
<name><surname>Klinger</surname><given-names>F</given-names></name>
<name><surname>Villani</surname><given-names>F</given-names></name>
<name><surname>Fossati</surname><given-names>C</given-names></name>
<name><surname>Vinci</surname><given-names>V</given-names></name>
<name><surname>Klinger</surname><given-names>M</given-names></name>
</person-group>. <article-title>Correction of cicatricial ectropion by autologous fat graft</article-title>. <source>Aesthetic Plast Surg</source>. <year>2008</year>;<volume>32</volume>(<issue>3</issue>):<fpage>555</fpage>-<lpage>557</lpage>.</citation>
</ref>
<ref id="bibr39-1090820X12455658">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Coleman</surname><given-names>SR</given-names></name>
<name><surname>Saboeiro</surname><given-names>AP</given-names></name>
</person-group>. <article-title>Fat grafting to the breast revisited: safety and efficacy</article-title>. <source>Plast Reconstr Surg</source>. <year>2007</year>;<volume>119</volume>(<issue>3</issue>):<fpage>775</fpage>-<lpage>785</lpage>; <comment>discussion 786-787</comment>.</citation>
</ref>
<ref id="bibr40-1090820X12455658">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Del Vecchio</surname><given-names>DA</given-names></name>
<name><surname>Bucky</surname><given-names>LP</given-names></name>
</person-group>. <article-title>Breast augmentation using preexpansion and autologous fat transplantation: a clinical radiographic study</article-title>. <source>Plast Reconstr Surg</source>. <year>2011</year>;<volume>127</volume>(<issue>6</issue>):<fpage>2441</fpage>-<lpage>2450</lpage>.</citation>
</ref>
<ref id="bibr41-1090820X12455658">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Veber</surname><given-names>M</given-names></name>
<name><surname>Tourasse</surname><given-names>C</given-names></name>
<name><surname>Toussoun</surname><given-names>G</given-names></name>
<name><surname>Moutran</surname><given-names>M</given-names></name>
<name><surname>Mojallal</surname><given-names>A</given-names></name>
<name><surname>Delay</surname><given-names>E</given-names></name>
</person-group>. <article-title>Radiographic findings after breast augmentation by autologous fat transfer</article-title>. <source>Plast Reconstr Surg</source>. <year>2011</year>;<volume>127</volume>(<issue>3</issue>):<fpage>1289</fpage>-<lpage>1299</lpage>.</citation>
</ref>
<ref id="bibr42-1090820X12455658">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Petit</surname><given-names>JY</given-names></name>
<name><surname>Lohsiriwat</surname><given-names>V</given-names></name>
<name><surname>Clough</surname><given-names>KB</given-names></name>
<etal/>
</person-group>. <article-title>The oncologic outcome and immediate surgical complications of lipofilling in breast cancer patients: a multicenter study—Milan-Paris-Lyon experience of 646 lipofilling procedures</article-title>. <source>Plast Reconstr Surg</source>. <year>2011</year>;<volume>128</volume>(<issue>2</issue>):<fpage>341</fpage>-<lpage>346</lpage>.</citation>
</ref>
<ref id="bibr43-1090820X12455658">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Delay</surname><given-names>E</given-names></name>
<name><surname>Garson</surname><given-names>S</given-names></name>
<name><surname>Tousson</surname><given-names>G</given-names></name>
<name><surname>Sinna</surname><given-names>R</given-names></name>
</person-group>. <article-title>Fat injection to the breast: technique, results, and indications based on 880 procedures over 10 years</article-title>. <source>Aesthetic Surg J</source>. <year>2009</year>;<volume>29</volume>(<issue>5</issue>):<fpage>360</fpage>-<lpage>376</lpage>.</citation>
</ref>
<ref id="bibr44-1090820X12455658">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Spear</surname><given-names>SL</given-names></name>
<name><surname>Wilson</surname><given-names>HB</given-names></name>
<name><surname>Lockwood</surname><given-names>MD</given-names></name>
</person-group>. <article-title>Fat injection to correct contour deformities in the reconstructed breast</article-title>. <source>Plast Reconstr Surg</source>. <year>2005</year>;<volume>116</volume>(<issue>5</issue>):<fpage>1300</fpage>-<lpage>1305</lpage>.</citation>
</ref>
<ref id="bibr45-1090820X12455658">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kanchwala</surname><given-names>SK</given-names></name>
<name><surname>Glatt</surname><given-names>BS</given-names></name>
<name><surname>Conant</surname><given-names>EF</given-names></name>
<name><surname>Bucky</surname><given-names>LP</given-names></name>
</person-group>. <article-title>Autologous fat grafting to the reconstructed breast: the management of acquired contour deformities</article-title>. <source>Plast Reconstr Surg</source>. <year>2009</year>;<volume>124</volume>(<issue>2</issue>):<fpage>409</fpage>-<lpage>418</lpage>.</citation>
</ref>
<ref id="bibr46-1090820X12455658">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sinna</surname><given-names>R</given-names></name>
<name><surname>Delay</surname><given-names>E</given-names></name>
<name><surname>Garson</surname><given-names>S</given-names></name>
<name><surname>Delaporte</surname><given-names>T</given-names></name>
<name><surname>Toussoun</surname><given-names>G</given-names></name>
</person-group>. <article-title>Breast fat grafting (lipomodelling) after extended latissimus dorsi flap breast reconstruction: a preliminary report of 200 consecutive cases</article-title>. <source>J Plast Reconstr Aesthetic Surg</source>. <year>2010</year>;<volume>63</volume>(<issue>11</issue>):<fpage>1769</fpage>-<lpage>1777</lpage>.</citation>
</ref>
<ref id="bibr47-1090820X12455658">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sarfati</surname><given-names>I</given-names></name>
<name><surname>Ihrai</surname><given-names>T</given-names></name>
<name><surname>Kaufman</surname><given-names>G</given-names></name>
<name><surname>Nos</surname><given-names>C</given-names></name>
<name><surname>Clough</surname><given-names>KB</given-names></name>
</person-group>. <article-title>Adipose-tissue grafting to the post-mastectomy irradiated chest wall: preparing the ground for implant reconstruction</article-title>. <source>J Plast Reconstr Aesthetic Surg</source>. <year>2011</year>;<volume>64</volume>(<issue>9</issue>):<fpage>1161</fpage>-<lpage>1166</lpage>.</citation>
</ref>
<ref id="bibr48-1090820X12455658">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Panettiere</surname><given-names>P</given-names></name>
<name><surname>Accorsi</surname><given-names>D</given-names></name>
<name><surname>Marchetti</surname><given-names>L</given-names></name>
<name><surname>Sgrò</surname><given-names>F</given-names></name>
<name><surname>Sbarbati</surname><given-names>A</given-names></name>
</person-group>. <article-title>Large-breast reconstruction using fat graft only after prosthetic reconstruction failure</article-title>. <source>Aesthetic Plast Surg</source>. <year>2011</year>;<volume>35</volume>(<issue>5</issue>):<fpage>703</fpage>-<lpage>708</lpage>.</citation>
</ref>
<ref id="bibr49-1090820X12455658">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Babovic</surname><given-names>S</given-names></name>
</person-group>. <article-title>Complete breast reconstruction with autologous fat graft - a case report</article-title>. <source>J Plast Reconstr Aesthetic Surg</source>. <year>2010</year>;<volume>63</volume>(<issue>7</issue>):<fpage>e561</fpage>-<lpage>e563</lpage>.</citation>
</ref>
<ref id="bibr50-1090820X12455658">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Khouri</surname><given-names>R</given-names></name>
<name><surname>Del Vecchio</surname><given-names>D</given-names></name>
</person-group>. <article-title>Breast reconstruction and augmentation using pre-expansion and autologous fat transplantation</article-title>. <source>Clin Plast Surg</source>. <year>2009</year>;<volume>36</volume>(<issue>2</issue>):<fpage>269</fpage>-<lpage>280</lpage>, <fpage>viii</fpage>.</citation>
</ref>
<ref id="bibr51-1090820X12455658">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zuk</surname><given-names>PA</given-names></name>
<name><surname>Zhu</surname><given-names>M</given-names></name>
<name><surname>Ashjian</surname><given-names>P</given-names></name>
<etal/>
</person-group>. <article-title>Human adipose tissue is a source of multipotent stem cells</article-title>. <source>Mol Biol Cell</source>. <year>2002</year>;<volume>13</volume>(<issue>12</issue>):<fpage>4279</fpage>-<lpage>4295</lpage>.</citation>
</ref>
<ref id="bibr52-1090820X12455658">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Crisan</surname><given-names>M</given-names></name>
<name><surname>Yap</surname><given-names>S</given-names></name>
<name><surname>Casteilla</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>A perivascular origin for mesenchymal stem cells in multiple human organs</article-title>. <source>Cell Stem Cell</source>. <year>2008</year>;<volume>3</volume>(<issue>3</issue>):<fpage>301</fpage>-<lpage>313</lpage>.</citation>
</ref>
<ref id="bibr53-1090820X12455658">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>da Silva Meirelles</surname><given-names>L</given-names></name>
<name><surname>Caplan</surname><given-names>AI</given-names></name>
<name><surname>Nardi</surname><given-names>NB</given-names></name>
</person-group>. <article-title>In search of the in vivo identity of mesenchymal stem cells</article-title>. <source>Stem Cells</source>. <year>2008</year>;<volume>26</volume>:<fpage>2281</fpage>-<lpage>2299</lpage>.</citation>
</ref>
<ref id="bibr54-1090820X12455658">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zimmerlin</surname><given-names>L</given-names></name>
<name><surname>Donnenberg</surname><given-names>VS</given-names></name>
<name><surname>Pfeifer</surname><given-names>ME</given-names></name>
<etal/>
</person-group>. <article-title>Stromal vascular progenitors in adult human adipose tissue</article-title>. <source>Cytometry A</source>. <year>2010</year>;<volume>77</volume>(<issue>1</issue>):<fpage>22</fpage>-<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr55-1090820X12455658">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Choi</surname><given-names>JH</given-names></name>
<name><surname>Gimble</surname><given-names>JM</given-names></name>
<name><surname>Lee</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Adipose tissue engineering for soft tissue regeneration</article-title>. <source>Tissue Eng Part B Rev</source>. <year>2010</year>;<volume>16</volume>(<issue>4</issue>):<fpage>413</fpage>-<lpage>426</lpage>.</citation>
</ref>
<ref id="bibr56-1090820X12455658">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kang</surname><given-names>JH</given-names></name>
<name><surname>Gimble</surname><given-names>JM</given-names></name>
<name><surname>Kaplan</surname><given-names>DL</given-names></name>
</person-group>. <article-title>In vitro 3D model for human vascularized adipose tissue</article-title>. <source>Tissue Eng Part A</source>. <year>2009</year>;<volume>15</volume>(<issue>8</issue>):<fpage>2227</fpage>-<lpage>2236</lpage>.</citation>
</ref>
<ref id="bibr57-1090820X12455658">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>L’Heureux</surname><given-names>N</given-names></name>
<name><surname>Pâquet</surname><given-names>S</given-names></name>
<name><surname>Labbé</surname><given-names>R</given-names></name>
<name><surname>Germain</surname><given-names>L</given-names></name>
<name><surname>Auger</surname><given-names>FA</given-names></name>
</person-group>. <article-title>A completely biological tissue-engineered human blood vessel</article-title>. <source>FASEB J</source>. <year>1998</year>;<volume>12</volume>(<issue>1</issue>):<fpage>47</fpage>-<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr58-1090820X12455658">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>L’Heureux</surname><given-names>N</given-names></name>
<name><surname>Dusserre</surname><given-names>N</given-names></name>
<name><surname>Konig</surname><given-names>G</given-names></name>
<etal/>
</person-group>. <article-title>Human tissue-engineered blood vessels for adult arterial revascularization</article-title>. <source>Nat Med</source>. <year>2006</year>;<volume>12</volume>(<issue>3</issue>):<fpage>361</fpage>-<lpage>365</lpage>.</citation>
</ref>
<ref id="bibr59-1090820X12455658">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wong</surname><given-names>VW</given-names></name>
<name><surname>Rustad</surname><given-names>KC</given-names></name>
<name><surname>Longaker</surname><given-names>MT</given-names></name>
<name><surname>Gurtner</surname><given-names>GC</given-names></name>
</person-group>. <article-title>Tissue engineering in plastic surgery: a review</article-title>. <source>Plast Reconstr Surg</source>. <year>2010</year>;<volume>126</volume>(<issue>3</issue>):<fpage>858</fpage>-<lpage>868</lpage>.</citation>
</ref>
<ref id="bibr60-1090820X12455658">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Langer</surname><given-names>R</given-names></name>
<name><surname>Vacanti</surname><given-names>JP</given-names></name>
</person-group>. <article-title>Tissue engineering</article-title>. <source>Science</source>. <year>1993</year>;<volume>260</volume>(<issue>5110</issue>):<fpage>920</fpage>-<lpage>926</lpage>.</citation>
</ref>
<ref id="bibr61-1090820X12455658">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hemmrich</surname><given-names>K</given-names></name>
<name><surname>von Heimburg</surname><given-names>D</given-names></name>
<name><surname>Cierpka</surname><given-names>K</given-names></name>
<name><surname>Haydarlioglu</surname><given-names>S</given-names></name>
<name><surname>Pallua</surname><given-names>N</given-names></name>
</person-group>. <article-title>Optimization of the differentiation of human preadipocytes in vitro</article-title>. <source>Differentiation</source>. <year>2005</year>;<volume>73</volume>(<issue>1</issue>):<fpage>28</fpage>-<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr62-1090820X12455658">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wada</surname><given-names>T</given-names></name>
<name><surname>Ihunnah</surname><given-names>CA</given-names></name>
<name><surname>Gao</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Estrogen sulfotransferase inhibits adipocyte differentiation</article-title>. <source>Mol Endocrinol</source>. <year>2011</year>;<volume>25</volume>(<issue>9</issue>):<fpage>1612</fpage>-<lpage>1623</lpage>.</citation>
</ref>
<ref id="bibr63-1090820X12455658">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Matsumoto</surname><given-names>D</given-names></name>
<name><surname>Sato</surname><given-names>K</given-names></name>
<name><surname>Gonda</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Cell-assisted lipotransfer: supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection</article-title>. <source>Tissue Eng</source>. <year>2006</year>;<volume>12</volume>(<issue>12</issue>):<fpage>3375</fpage>-<lpage>3382</lpage>.</citation>
</ref>
<ref id="bibr64-1090820X12455658">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshimura</surname><given-names>K</given-names></name>
<name><surname>Sato</surname><given-names>K</given-names></name>
<name><surname>Aoi</surname><given-names>N</given-names></name>
<etal/>
</person-group>. <article-title>Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adipose-derived stem cells</article-title>. <source>Dermatol Surg</source>. <year>2008</year>;<volume>34</volume>(<issue>9</issue>):<fpage>1178</fpage>-<lpage>1185</lpage>.</citation>
</ref>
<ref id="bibr65-1090820X12455658">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshimura</surname><given-names>K</given-names></name>
<name><surname>Asano</surname><given-names>Y</given-names></name>
<name><surname>Aoi</surname><given-names>N</given-names></name>
<etal/>
</person-group>. <article-title>Progenitor-enriched adipose tissue transplantation as rescue for breast implant complications</article-title>. <source>Breast J</source>. <year>2010</year>;<volume>16</volume>(<issue>2</issue>):<fpage>169</fpage>-<lpage>175</lpage>.</citation>
</ref>
<ref id="bibr66-1090820X12455658">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sun</surname><given-names>F</given-names></name>
<name><surname>Zhou</surname><given-names>K</given-names></name>
<name><surname>Mi</surname><given-names>WJ</given-names></name>
<name><surname>Qiu</surname><given-names>JH</given-names></name>
</person-group>. <article-title>Combined use of decellularized allogeneic artery conduits with autologous transdifferentiated adipose-derived stem cells for facial nerve regeneration in rats</article-title>. <source>Biomaterials</source>. <year>2011</year>;<volume>32</volume>(<issue>32</issue>):<fpage>8118</fpage>-<lpage>8128</lpage>.</citation>
</ref>
<ref id="bibr67-1090820X12455658">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zografou</surname><given-names>A</given-names></name>
<name><surname>Tsigris</surname><given-names>C</given-names></name>
<name><surname>Papadopoulos</surname><given-names>O</given-names></name>
<etal/>
</person-group>. <article-title>Improvement of skin-graft survival after autologous transplantation of adipose-derived stem cells in rats</article-title>. <source>J Plast Reconstr Aesthetic Surg</source>. <year>2011</year>;<volume>64</volume>(<issue>12</issue>):<fpage>1647</fpage>-<lpage>1656</lpage>.</citation>
</ref>
<ref id="bibr68-1090820X12455658">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pak</surname><given-names>J</given-names></name>
</person-group>. <article-title>Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: a case series</article-title>. <source>J Med Case Rep</source>. <year>2011</year>;<volume>5</volume>(<issue>1</issue>):<fpage>296</fpage>.</citation>
</ref>
<ref id="bibr69-1090820X12455658">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shi</surname><given-names>CZ</given-names></name>
<name><surname>Zhang</surname><given-names>XP</given-names></name>
<name><surname>Lv</surname><given-names>ZW</given-names></name>
<etal/>
</person-group>. <article-title>Adipose tissue-derived stem cells embedded with eNOS restore cardiac function in acute myocardial infarction model</article-title>. <source>Int J Cardiol</source>. <year>2012</year>;<volume>154</volume>(<issue>1</issue>):<fpage>2</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr70-1090820X12455658">
<label>70.</label>
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Auclair</surname><given-names>EM</given-names></name>
<name><surname>Szpalski</surname><given-names>C</given-names></name>
</person-group>. <article-title>Composite breast augmentation</article-title>. <conf-name>Presented at: International Federation for Adipose Therapeutics and Science 9th Annual Meeting</conf-name>; <conf-date>November 3-6, 2011</conf-date>, <conf-loc>Miami, FL</conf-loc>.</citation>
</ref>
<ref id="bibr71-1090820X12455658">
<label>71.</label>
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Levovitz</surname><given-names>C</given-names></name>
<name><surname>Karp</surname><given-names>NS</given-names></name>
<name><surname>Choi</surname><given-names>M</given-names></name>
</person-group>. <article-title>Fat grafting to the reconstructed breast: the use of 3D imaging to evaluate volume retention</article-title>. <conf-name>Presented at: International Federation for Adipose Therapeutics and Science 9th Annual Meeting</conf-name>; <conf-date>November 3-6, 2011</conf-date>, <conf-loc>Miami, FL</conf-loc>.</citation>
</ref>
<ref id="bibr72-1090820X12455658">
<label>72.</label>
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>L-T</given-names></name>
<name><surname>Teng</surname><given-names>S-C</given-names></name>
<name><surname>Lin</surname><given-names>Y-H</given-names></name>
<name><surname>Fang</surname><given-names>H-W</given-names></name>
</person-group>. <article-title>Dose-dependent effect of adipose-derived stromal vascular fraction cells improve angiogenesis and anti-inflammation of human fat graft</article-title>. <conf-name>Presented at: International Federation for Adipose Therapeutics and Science 9th Annual Meeting</conf-name>; <conf-date>November 3-6, 2011</conf-date>, <conf-loc>Miami, FL</conf-loc>.</citation>
</ref>
<ref id="bibr73-1090820X12455658">
<label>73.</label>
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Watson</surname><given-names>JP</given-names></name>
</person-group>. <article-title>Clinical comparison of three commercially made SVF extraction machines</article-title>. <conf-name>Presented at: International Federation for Adipose Therapeutics and Science 9th Annual Meeting</conf-name>; <conf-date>November 3-6, 2011</conf-date>, <conf-loc>Miami, FL</conf-loc>.</citation>
</ref>
<ref id="bibr74-1090820X12455658">
<label>74.</label>
<citation citation-type="confproc">
<conf-name>The Cutting Edge 2011: 31st Aesthetic Surgery Symposium</conf-name>; <conf-date>December 1-3, 2011</conf-date>; <conf-loc>New York, NY</conf-loc>.</citation>
</ref>
</ref-list>
</back>
</article>